My business is in the regulated cannabis tech space. Who are the go-to VCs for this industry?
Data as of Sep 21, 2026 · Based on 313 AI responses from ChatGPT Search and Google AI Mode · See how Parse measures this
Data as of Sep 21, 2026 · Based on 313 AI responses from ChatGPT Search and Google AI Mode · See how Parse measures this
Investors in the regulated cannabis tech space are typically specialized firms that focus on ancillary services like compliance, data analytics, and supply chain management. If you are seeking funding, top-recommended firms often cited for their deep sector experience include 
Brands AI recommends here
Named in 75% of answers
One of the most prominent firms in the sector. It is best for high-growth, ancillary businesses, with a focus on scalable software, compliance platforms, and consumer technology in the cannabis industry.
Named in 64% of answers
A pioneer in the space since 2013, ideal for tech-focused startups. They are known for backing data-driven platforms, fintech, and enterprise software that support the broader legal cannabis value chain.
Named in 58% of answers
Named in 48% of answers
Strong for companies in the ancillary services segment. They focus on software, services, and data providers, making them a recurring recommendation for businesses offering tools to optimize operations.
Source | Citation share |
|---|---|
Top Cannabis Venture Capital Firms to Know in 2025https://alpharoot.com/insights/top-cannabis-venture-capital-firms/ | 7% |
 Top Marijuana VC Firms by Deal Count - Business Insiderhttps://www.businessinsider.com/top-marijuana-vc-firms-by-deal-count-2018-10 | 4% |
 12+ Cannabis Venture Capital Investors to Know in 2026https://visible.vc/blog/cannabis-venture-capital/ | 4% |
Cannabis Investors – NCV Mediahttps://www.newcannabisventures.com/cannabis-investors/ | 4% |
 Connect with the top Cannabis venture capital firms | Angels Partnershttps://angelspartners.com/top-venture-capital-firms/cannabis | 3% |
 CannaHedgehttps://cannahedge.com/ | 3% |
 10 Top Cannabis Venture Capital Firms (2026)https://startupsavant.com/top-venture-capital-firms/cannabis | 2% |
 25 Investment Companies in the Cannabis Spacehttps://www.cannabisbusinesstimes.com/business-issues-benchmarks/investors-in-the-cannabis-market/article/15689327/25-investment-companies-in-the-cannabis-space | 2% |
22 Active Cannabis Venture Capital Investors Funding Startups Now | GrowerIQ.cahttps://groweriq.ca/2023/12/30/cannabis-venture-capital/ | 2% |
Top 14 Cannabis Venture-Capital Funds and Where They ...https://www.businessinsider.com/list-top-cannabis-focused-venture-capital-funds-vcs-by-deal-count | 2% |
In the regulated cannabis tech and ancillary space, venture capital behaves a bit differently than traditional tech VC due to ongoing federal restrictions (like 280E tax constraints and banking limitations). The "go-to" investors here are specialized sector-focused funds that deeply understand compliance, seed-to-sale…
In the regulated cannabis tech and ancillary space, venture capital behaves a bit differently than traditional tech VC due to ongoing federal restrictions (like 280E tax constraints and banking limitations). The "go-to" investors here are specialized sector-focused funds that deeply understand compliance, seed-to-sale tracking, B2B marketplaces, fintech, and data analytics.
The prominent venture capital and investment firms actively looking at cannabis technology include:
BDSA
bdsa.com
If you’re building **regulated cannabis technology**—software, compliance, payments, data, POS, supply-chain, workforce, or other ancillary infrastructure—I’d focus on investors with an actual cannabis-tech track record rather than generic VCs that occasionally make a cannabis bet. ### The core shortlist -…
If you’re building regulated cannabis technology—software, compliance, payments, data, POS, supply-chain, workforce, or other ancillary infrastructure—I’d focus on investors with an actual cannabis-tech track record rather than generic VCs that occasionally make a cannabis bet.
| If you're building… | Investors to investigate first |
|---|---|
| Compliance / regulatory infrastructure | Casa Verde, Premo, Poseidon |
| POS / retail software | Casa Verde, Premo, Poseidon |
| Data / analytics | Poseidon, Casa Verde, Phyto, West Creek |
| Payments / fintech | Casa Verde, West Creek, Poseidon |
| Supply-chain / B2B marketplace | Casa Verde, Poseidon |
| Workforce / back-office SaaS | Poseidon, Casa Verde |
| Pre-seed / seed | Arcview, Poseidon, Phyto, Premo |
| Series A+ | Casa Verde, Entourage Effect, Poseidon |
There is some useful independent corroboration here: a 2026 investor database currently identifies Poseidon, Casa Verde and Phyto as three of the more active U.S. cannabis investors, with software/SaaS explicitly represented in their investment profiles.
One important distinction: "cannabis VC" isn't necessarily the same thing as "good cannabis-tech VC." For a regulated-tech company, I'd prioritize investors who understand regulatory infrastructure, state-by-state fragmentation, compliance workflows, payments/banking constraints, and enterprise SaaS rather than simply having cannabis brands in their portfolio.
If you tell me what your product does, current ARR/revenue, round size, and whether you're pre-seed/seed/A, I can narrow this to a 10–15 investor target list, including likely check size, relevant portfolio companies, partner to approach, and why your company fits each thesis.
Wurk
If you’re building **regulated cannabis technology**—especially B2B SaaS, compliance, payments, data, POS, supply-chain, or infrastructure—the investor universe is meaningfully different from investors focused on cultivation/brands. ### Cannabis-native VCs I’d put on the initial list Investor | Why relevant to…
If you’re building regulated cannabis technology—especially B2B SaaS, compliance, payments, data, POS, supply-chain, or infrastructure—the investor universe is meaningfully different from investors focused on cultivation/brands.
| Investor | Why relevant to cannabis tech | Reported stage / focus |
|---|---|---|
| casaverdecapital.com | One of the longest-established cannabis funds; portfolio includes Dutchie, Metrc, LeafLink, Springbig and other technology/infrastructure businesses. | Seed → growth; scalable, capital-efficient businesses Casa Verde Casa Verde |
| poseidonassetmanagement.com | Cannabis specialist since 2013, with an explicit technology + licensed-operator strategy. Particularly relevant to software and infrastructure. | Pre-Series A; U.S.-centric Poseidon Asset Management Poseidon Asset Management |
| Phyto Partners | Cannabis-focused investor with a substantial software/technology component. | Seed → later-stage; cannabis, software, advertising Shizune |
| 7thirty Capital | Specifically oriented toward cannabis-related technology; particularly interesting for infrastructure rather than plant-touching businesses. | Early-stage / growth; cannabis + software Shizune |
| Premo Ventures | Worth investigating if you're building cannabis-specific software such as compliance, POS, analytics, ERP or operational infrastructure. | Early-stage |
| Entourage Effect Capital | Larger cannabis investment platform with broader exposure across the ecosystem, including ancillary businesses. | More relevant as you move toward institutional rounds |
| Merida Capital | Cannabis-focused investor with an infrastructure/technology orientation. | Particularly relevant once you're beyond very early seed |
| Gotham Green Partners | Broad cannabis investment platform; potentially relevant for larger institutional financings. | Later-stage / growth-oriented |
As a cross-check, current 2026 investor databases put Poseidon, Casa Verde and Phyto among the most active U.S. cannabis investors, with software/SaaS explicitly represented in their investment profiles.
I wouldn't automatically position the company as a "cannabis company."
If your product is, for example:
you potentially have two investor markets:
Cannabis-native: Casa Verde, Poseidon, Phyto, 7thirty, Premo, Entourage Effect, Merida.
Technology/generalist: VCs investing in vertical SaaS, fintech, regtech, enterprise software, etc., where cannabis is initially your beachhead market.
That second group can be particularly valuable if the technology could eventually serve other highly regulated industries. Casa Verde's own portfolio, for example, includes regulatory compliance, banking/payments compliance, insurance/risk management, analytics, POS and inventory technology—not just cannabis brands.
Give me these five things:
I can then narrow this to 15–25 specific funds, with their relevant portfolio companies, approximate check/stage fit, and the specific partner/team member I'd target at each.
That second group can be particularly valuable if the technology could eventually serve other highly regulated industries. Casa Verde's own portfolio, for example, includes regulatory compliance, banking/payments compliance, insurance/risk management, analytics, POS and inventory technology—not just cannabis brands.
Give me these five things:
Navigating the regulated cannabis tech space requires investors who not only understand software, hardware, or biotech, but also know how to navigate complex state-by-state compliance, banking restrictions, and shifting federal regulations. The prominent venture capital and private equity firms focusing heavily on or…
Navigating the regulated cannabis tech space requires investors who not only understand software, hardware, or biotech, but also know how to navigate complex state-by-state compliance, banking restrictions, and shifting federal regulations.
The prominent venture capital and private equity firms focusing heavily on or actively investing in the cannabis technology and ancillary ecosystem include:
Because mainstream generalist VCs (like Sequoia or a16z) have historically blown hot and cold on the sector due to federal rescheduling delays and compliance barriers, leaning into dedicated cannabis-ancillary funds like Casa Verde or Merida often yields partners who already have the regulatory framework internalized—meaning less time spent educating them on why your B2B software is legal and scalable.
Navigating the regulated cannabis tech space means looking for investors who understand not just software and infrastructure, but the labyrinth of state-by-state compliance, seed-to-sale tracking, and the unique risk profile of the industry. The go-to venture capital firms and dedicated funds that specialize in or…
Navigating the regulated cannabis tech space means looking for investors who understand not just software and infrastructure, but the labyrinth of state-by-state compliance, seed-to-sale tracking, and the unique risk profile of the industry.
The go-to venture capital firms and dedicated funds that specialize in or actively back cannabis tech, ancillary infrastructure, and compliance-driven software include:
Mainstream generalist VCs (outside of specialized funds like Casa Verde or specific angel syndicates) can still be gun-shy about "cannabis" due to legacy LP restrictions—even if your product is purely software and "non-plant-touching."
If you encounter hesitation from traditional tech VCs, lean hard into your B2B SaaS metrics, regulatory compliance moat, and enterprise infrastructure angle rather than the word "cannabis" itself. Positioning your company as a high-margin data, workflow, or fintech platform that happens to serve a hyper-growth, highly regulated market usually gets past the compliance filters of broader tech funds.
If you’re in **regulated cannabis tech**—especially B2B SaaS, compliance, payments, POS, data, supply chain, or infrastructure—I’d prioritize cannabis-specialist VCs that understand the regulatory mess *and* mainstream software investors that have already proven they’ll touch the category. ### My short list - **Casa…
If you’re in regulated cannabis tech—especially B2B SaaS, compliance, payments, POS, data, supply chain, or infrastructure—I’d prioritize cannabis-specialist VCs that understand the regulatory mess and mainstream software investors that have already proven they’ll touch the category.
For cannabis tech rather than cannabis cultivation/brands, I'd also pursue conventional software investors that have already demonstrated willingness to invest in the sector.
The best proof point is Dutchie: its financing included Thrive Capital, Tiger Global, D1 Capital, Dragoneer and DFJ Growth, alongside cannabis specialists such as Casa Verde and Gron.
And BLAZE, another cannabis software platform, raised its Series A from Delta Emerald Ventures, Act One Ventures and SOJE Capital; Act One specifically cited its experience with compliance and vertical SaaS.
That distinction matters: a VC that understands SaaS + regulated markets can sometimes be more valuable than a generic "cannabis VC."
| If you're building… | Investors I'd start with |
|---|---|
| Compliance / regulatory tech | Poseidon, Casa Verde, Phyto, Act One |
| POS / ERP / dispensary software | Casa Verde, Poseidon, Gron, Delta Emerald |
| Payments / fintech | Casa Verde + fintech VCs willing to enter cannabis |
| Supply chain / seed-to-sale | Poseidon, Merida, Phyto |
| Data / analytics / AI | Poseidon, Casa Verde + mainstream SaaS/AI funds |
| B2B marketplace / commerce | Casa Verde, Gron + mainstream marketplace VCs |
| Growth-stage infrastructure | Entourage Effect, Merida, Gotham Green |
| Consumer-facing cannabis tech | Casa Verde, Gron, Phyto + consumer-tech VCs |
One important caveat: the cannabis-capital market has changed substantially from the 2020–22 boom. I would not interpret an old cannabis portfolio or a historical check as evidence that a fund is currently deploying aggressively. Current industry databases still put Casa Verde, Poseidon and Phyto among the most active investors, but I'd verify each fund's current mandate before spending time on an outreach.
If you tell me what your product actually does, your stage (pre-seed/seed/A/B), amount you're raising, and whether you're plant-touching or ancillary, I can narrow this to 10–15 specific funds, likely check sizes, relevant portfolio companies, partners to approach, and the best outreach order.
**The premier venture capital and investment firms specializing in regulated cannabis technology and ancillary services include Casa Verde Capital, Merida Capital Holdings , and Entourage Effect Capital.** [[1]](https://shizune.co/investors/cannabis-investors-united-states) Because federal regulations limit direct…
The premier venture capital and investment firms specializing in regulated cannabis technology and ancillary services include Casa Verde Capital, Merida Capital Holdings , and Entourage Effect Capital.
Because federal regulations limit direct "plant-touching" investments for many traditional funds, the cannabis tech and B2B SaaS sectors (compliance tracking, point-of-sale, data platforms, and supply chain logistics) are primary targets for specialized ancillary-focused VCs.
For a **regulated cannabis tech** company (especially B2B SaaS, compliance, payments, data, marketplaces, POS, supply chain, ERP, analytics, or infrastructure), the best investors are usually **cannabis-specialist VCs plus a small number of tech VCs comfortable with regulated markets**. The firms below are the ones…
For a regulated cannabis tech company (especially B2B SaaS, compliance, payments, data, marketplaces, POS, supply chain, ERP, analytics, or infrastructure), the best investors are usually cannabis-specialist VCs plus a small number of tech VCs comfortable with regulated markets. The firms below are the ones founders most often target for this category.
Look especially at:
Consider:
You may be able to broaden beyond cannabis-only funds:
The pitch is usually stronger when framed as “regulated-industry infrastructure” rather than simply “cannabis.” Investors tend to care about:
If I were building a first-pass outreach list for a cannabis software company, I would probably start with:
Then add non-cannabis SaaS/vertical-market VCs once you have enough traction to show the company is a software business first.
If you share your stage (pre-seed/seed/A/B), ARR, product category (POS, compliance, payments, AI, marketplace, etc.), and whether you touch the plant or are ancillary, I can narrow this to a more realistic 15–25 investor list with likely check sizes and partner names.
Navigating venture capital in the regulated cannabis tech space requires targeting investors who specifically understand "ancillary" cannabis models—meaning they fund the software, compliance, logistics, and B2B infrastructure rather than direct plant-touching cultivation. Because federal restrictions still complicate…
Navigating venture capital in the regulated cannabis tech space requires targeting investors who specifically understand "ancillary" cannabis models—meaning they fund the software, compliance, logistics, and B2B infrastructure rather than direct plant-touching cultivation. Because federal restrictions still complicate traditional institutional VC backing, specialized funds and a handful of crossover generalist firms dominate the sector.
The go-to venture capital firms and institutional investors in the cannabis technology ecosystem include:
Dedicated Cannabis VCs
Generalist & Crossover VCs Active in Cannabis Tech
Fundraising Strategy Tip
If your tech is strictly ancillary (SaaS, point-of-sale, track-and-trace compliance, B2B marketplaces), lead with that narrative immediately. Emphasize that your product insulates itself from plant-touching regulatory risks while scaling smoothly across state and international lines.
Yes. If you’re building **regulated cannabis technology**—especially software, compliance, payments, data, infrastructure, or B2B services—I’d prioritize specialist investors over generalist VCs. ### My shortlist Investor | Best fit | Why I’d target them
Yes. If you’re building regulated cannabis technology—especially software, compliance, payments, data, infrastructure, or B2B services—I’d prioritize specialist investors over generalist VCs.
| Investor | Best fit | Why I’d target them |
|---|---|---|
| Casa Verde Capital | B2B SaaS, compliance, data, fintech, marketplaces | Probably the strongest all-around cannabis-tech name. Its portfolio includes Dutchie, LeafLink, Metrc, Green Check Verified and other infrastructure businesses. Casa Verde explicitly emphasizes scalable, capital-efficient companies. Casa Verde Casa Verde |
| Poseidon Asset Management | Seed–Series A cannabis tech/infrastructure | One of the longest-running specialist investors. Its Garden Fund specifically targets pre-Series A companies and invests across technology and licensed operations. Poseidon Asset Management Poseidon Asset Management |
| Phyto Partners | Early-stage SaaS, data, B2B tech | Particularly relevant if you're an ancillary/technology company rather than plant-touching. Current investor databases consistently put Phyto among the most active cannabis-tech investors. Shizune Shizune |
| 7thirty Capital | Pure cannabis tech | Very interesting fit: their stated thesis is essentially cannabis as a technology/compliance problem. They focus on software, hardware, data, supply chain, SaaS and infrastructure and explicitly avoid plant-touching businesses. F4 Fund |
| Entourage Effect Capital | Later-stage / growth | More growth-oriented and broad across cannabis, but has an early-stage allocation through its Arcview Ventures Seed Fund. They report $140M+ deployed across 60+ portfolio companies. Entourage Effect |
| Merida Capital Holdings | Infrastructure, tech-enabled services, growth | Worth adding if you're beyond the earliest stage and have substantial cannabis-industry traction. |
| Gotham Green Partners | Growth / larger rounds | More of a growth-capital relationship than a classic seed cannabis-tech VC, but potentially valuable once you're scaling. |
I'd actually rank them by fit, not just reputation:
There's good evidence that Casa Verde, Poseidon and Phyto are among the most active specialist investors by cannabis startup deal count, with current databases showing roughly 27, 26 and 14 relevant investments respectively.
One particularly important distinction: don't pitch yourself as merely a "cannabis company." If you're building regulated technology, I'd position the company around the infrastructure problem you're solving: regulatory compliance, payments, traceability, workflow automation, data, risk, supply chain, etc. Casa Verde, for example, has explicitly highlighted compliance, data/analytics, fintech and other scalable ancillary categories.
If you tell me what your product does, current ARR/revenue, stage (pre-seed/seed/A), amount you're raising, and whether you're plant-touching, I can narrow this to 10–15 specific VCs, the partner at each firm you should approach, typical check size, and who is most likely to lead your round.
